Philadelphia
•
Miami
•
Minneapolis
•
Los Angeles
Home
About Us
Our Qui Tam Lawyers
Notable Cases
Locations
Types of Fraud
Pharmaceutical Fraud
Off-Label Marketing
Medical Device and Medical Implant Fraud
Medicare Part D Fraud
Best Price Fraud
Pharmaceutical Kickbacks
Good Manufacturing Practice Violations
DESI Drugs
Medicaid Price Reporting
Manufactured Compound Drugs
Healthcare Fraud
Medicare and Medicaid Fraud
Anti-Kickback Statute
Stark Statute
Medical Device and Medical Implant Fraud
Ambulance Fraud
Cost Report Fraud
Durable Medical Equipment Fraud
Upcoding and Unbundling Fraud
Home Healthcare Fraud
Rehabilitation Services Fraud
Skilled Nursing Facility Fraud
Hospital Inpatient Fraud
Hospital Outpatient Fraud
LTACH Fraud
Medicare Advantage Risk-Scoring Fraud
Physicians as Whistleblowers
Financial Industry Fraud
TARP Fraud
Mortgage Fraud
Procurement Fraud
Defense Contractor Fraud
General Services Administration Fraud
Government Grant and Research Fraud
Department of Education Fraud
SEC Fraud
SEC & CFTC Whistleblower Programs
Types of Securities Fraud
Late Trading
Insider Trading
Money Laundering
Violations of the Foreign Corrupt Practices Act
SEC Whistleblower Statute
CFTC Whistleblower Statute
False Claims Act
False Claims Statute
What is a False Claim?
How the False Claims Act Works
States False Claims Act
Whistleblower Rewards
Whistleblower Protection
Filing Process
Confidentiality
Whistleblower HIPAA Concerns
The Importance of Being a Whistleblower
Questions About Qui Tam Law
Tax Fraud
About Kenney & McCafferty, P.C.
Learn more about one of the premier qui tam law firms in the nation.
Have Questions About Qui Tam Law?
Get the answers about false claims and qui tam lawsuits, and how Kenney & McCafferty can help you.
Our Commitment to You
With our extensive knowledge, Kenney & McCafferty can guide you every step of the way.
Contact Us With Your Case
If you have knowledge of a false claim against the government, contact us today.
K&M In The News
Fri, 12/09/2011
Tax Court Agrees with Kenney & McCafferty Regarding Anonymity of Whistleblowers
Fri, 09/16/2011
K&M Founder, Brian Kenney, and Attorney Tavy Deming Discuss the Need to Punish Doctors Involved in Healthcare Fraud
Wed, 08/10/2011
J&J Reaches Agreement with U.S. on Risperdal Criminal Charge
Tue, 06/28/2011
K&M Attorney Tavy Deming Shares Her Thoughts with NPR on Fraud in Hospice Care
Fri, 05/27/2011
Renal Care Group Parent Company Must Pay U.S. $86.2M Under New Ruling
Wed, 05/18/2011
K&M Present Testimony on IRS Whistleblower Program
Fri, 02/25/2011
J&J Must Defend U.S. Kickback Lawsuit Claims, Judge Rules
Fri, 02/25/2011
J&J May Be Liable for Risperdal Kickback Scheme Despite “Legal” Contract
Tue, 02/22/2011
Number of Healthcare Defendants Increases in Fiscal Year 2010
Fri, 02/11/2011
CareSource Case Sheds Light on Ohio Whistleblower Laws
Wed, 02/02/2011
Attorney General Mike DeWine Announces $26 Million Medicaid Fraud Settlement with Dayton Managed Care Firm
Wed, 02/02/2011
CareSource to Pay $26 Million to United States, Ohio and 2 Whistleblowers
Tue, 02/01/2011
Caresource Pays $26M to Resolve False Claims Act Lawsuit
Thu, 01/27/2011
U.S. Probes Banks' Mortgage Practices
Tue, 11/09/2010
Hewlett-Packard Agrees to Pay $16.25 Million to Settle Federal Investigation into Illegal Bid-Rigging Involving Federal E-Rate Program
Wed, 10/27/2010
Drugmakers Face Rising Fines and Sentences
Wed, 07/21/2010
Federal Prosecutors Report Slowdown in the Filing of New Fraud Claims, Says Less Egregious Violations Cited
Mon, 07/12/2010
AstraZeneca pays $530 million to settle off-label allegations surrounding Seroquel in largest civil settlement to date
Tue, 09/08/2009
AIG of Drugmakers, Pfizer, Is Too Big to Be Guilty: Ann Woolner
Mon, 09/07/2009
Pfizer Finalizes Record $2.3 Billion Fraud Settlement
Thu, 01/15/2009
Eli Lilly Pays Record $1.4 Billion to Settle Federal and State Fraud Investigations into Illegal Off-Label Marketing Practices of Zyprexa
Tue, 09/09/2008
Brian Kenney: Weak FDA Opens Door To False Claims Act Enforcement
Call Us: 800-533-1015 |
Email
K&M In The
News
K&M
Notable Cases
Whistleblower
News
Read Our Blog
KM Cases with Recoveries Over $100 Million
Pfizer
Eli Lilly
AstraZeneca
Cephalon
Follow @whistleblowerKM
Recent Blog Posts
Blowing the Whistle on Foreign Corrupt Practices Act Violations
Novo Nordisk, Inc. to Pay $1,725,000 to Settle Whistleblower Claims
KM Case Results in $82.6 Million Judgment Against Renal Care Group
SEC Whistleblower Program Rules Available
SEC Adopts Final Whistleblower Program Rules